Neurobiology and neurochemistry of Rett syndrome

Brain and Development

Volumn 23, Issue SUPPL. 1, 2001, Pages

  Matsuishi, Toyojiro ^a   Yamashita, Yushiro ^a   Kusaga, Akira ^a  

^a KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Biogenic amines; Methyl CpG binding protein 2; Nerve growth factors; Neuromodulators; Neuropeptides; Neurotransmitters

Indexed keywords

BIOGENIC AMINE; METHYL CPG BINDING PROTEIN 2; NERVE GROWTH FACTOR; NEUROTRANSMITTER; NEUROTROPHIC FACTOR; SUBSTANCE P; UNCLASSIFIED DRUG;

CEREBROSPINAL FLUID; CONFERENCE PAPER; DOPAMINERGIC NERVE CELL; GENE MUTATION; HUMAN; LOCUS CERULEUS; NEOCORTEX; NEUROBIOLOGY; NEUROCHEMISTRY; RETT SYNDROME;

ADOLESCENT; ADULT; BRAIN CHEMISTRY; CENTRAL NERVOUS SYSTEM; CHILD; CHILD, PRESCHOOL; ENZYMES; FEMALE; HUMANS; NEURONS; NEUROTRANSMITTER AGENTS; RETT SYNDROME;

EID: 0035200455     PISSN: 03877604     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0387-7604(01)00380-1     Document Type: Conference Paper

References (39)

1. Diagnostic criteria for Rett syndrome
2. Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2
3. Pathophysiology of Rett syndrome
4. Polysomnography in the Rett syndrome
5. Cerebrospinal fluid biogenic amines and biopterin in Rett syndrome
6. Cerebrospinal fluid values for monoamine metabolites, gamma aminobutyric acid, and other amino compounds in Rett syndrome
7. Rett syndrome: neurobiological changes underlying specific symptoms
8. Rett syndrome: biogenic amines and metabolites in postmortem brain
9. Alteration in dopaminergic function in Rett syndrome
10. Dopaminergic D2 receptor SPECT imaging in Rett syndrome: increase of specific binding in striatum
11. Pathological changes in substantia nigra and basal forebrain neurons in Rett syndrome
12. Altered cholinergic function in the basal forebrain of girls with Rett syndrome
13. Neurotrophic factors in cerebrospinal fluid and serum of patients with Rett syndrome
14. Development of amino acid receptors in frontal cortex from girls with Rett syndrome
15. Elevated CSF glutamate in Rett syndrome
16. Abnormal expression of microtubule-associated protein 2 (MAP-2) in neocortex in Rett syndrome
17. Decrease in benzodiazepine receptor binding in the brain of adult Rett syndrome
18. Ketogenic diet in Rett syndrome
19. Rett syndrome: findings suggesting axonopathy and mitochondrial abnormalities
20. The Rett syndrome and CSF lactic patterns
21. The level of autoantibodies to nerve growth factor and S-100 protein in blood of Rett syndrome girls Abstract
22. Membrane cerebral lipids in Rett syndrome
23. Altered cerebellar ganglioside pattern in Rett syndrome
24. Human brain gangliosides: developmental changes from early fetal stage to advanced age
25. Hyperendorphinism in Rett syndrome: cause or result?
26. Cerebrospinal fluid studies in the Rett syndrome: biogenic amines and beta endorphins
27. Decreased cerebrospinal fluid levels of substance P in patients with Rett syndrome
28. Substance P in the human brain
29. Interaction of substance P with respiratory control system in the rat
30. Substance P immunoreactivity in Rett syndrome
31. Coexistence of neuronal messengers: an overview
32. Multiple co-existence of peptides and classical transmitters in peripheral autonomic and sensory neurons: functional and pharmacological implications
33. Neurotrophic effects of substance P on hippocampal neurons in vitro
34. Decreased cerebrospinal fluid levels of β-phenylethylamine in patients with Rett syndrome
35. Phenylethylaminergic mechanisms in attention-deficit disorder
36. Decreased cerebrospinal fluid β3-phenylethylamine in Parkinson's disease
37. Influence of mutation type and X chromosome inactivation on Rett syndrome phenotypes
38. Biological function of the methyl-CpG binding protein MECP2 Abstract